BrainEye
BrainEye is a Sydney-based healthtech company offering a smartphone eye-tracking app that delivers 60-second brain health assessments, targeting consumers, collision-sport athletes, and neurological-condition patients via a freemium subscription distributed through app stores.
- Company typePrivate
- Founded2020
- HeadquartersSydney, Australia
- Headcount51–100
- GTM typeB2C
- OfferingSoftware
What BrainEye does
BrainEye (formerly BioEye), operated by Neuro Optica Operations Pty Ltd (ACN 669 149 884), is a Sydney-based healthtech company founded in 2020 that provides smartphone-based eye-tracking software for brain health assessment. The core product is a mobile application that uses a smartphone camera to capture eye movements in response to visual stimuli and extract ocular motor biomarkers in approximately 60 seconds, surfacing results that may indicate changes associated with concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. The technology has been validated against scientific-grade eye trackers and through clinical trials overseen by the Monash University Neuroscience Department, with ethics approval from the Bellberry Human Research Ethics Committee.
BrainEye firmographics
Firmographics- Name
- BrainEye
- Legal name
- Neuro Optica Operations Pty Ltd ACN 669 149 884
- Website
- https://braineye.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BrainEye is a Sydney-based healthtech company offering a smartphone eye-tracking app that delivers 60-second brain health assessments, targeting consumers, collision-sport athletes, and neurological-condition patients via a freemium subscription distributed through app stores.
- Ownership category
- akta.pro rank
BrainEye industry classification
Industry- Product category
- Digital Health Brain Assessment Software
- NAICS
- Offices of Optometrists (621320)
- SIC
- Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Neurology Telemedicine Platforms (HLALAGAC)
- akta.pro secondary industries
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE), Behavioral & Neuroscience Research (Biometrics, Eye-Tracking, Neuromarketing) (MPAAALAN)
Keywords
Where BrainEye is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
BrainEye business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- App Subscription: BrainEye generates revenue through 12-month subscription plans for app access. Subscriptions extend for 12 months from registration and automatically renew unless cancelled. Pricing varies by region and subscription type. Subscribers receive access to the BrainEye app, brain health tests, and result tracking.
- In-App Purchases: Subscriptions can be purchased as In-App Purchases via Apple App Store or Google Play Store. Users must manage cancellations through the respective platform's subscription management system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standard 12-month subscription with automatic renewal |
| Freemium | Annual | Free basic access with premium subscription for full features |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
BrainEye product offering
Product offeringCore offering
BrainEye offers a smartphone-based eye-tracking application that measures brain health by tracking eye responses to visual stimuli in 60 seconds. The app captures ocular motor biomarkers via the smartphone camera, uploads them to a cloud platform, and applies AI/ML analysis to deliver real-time results that can indicate concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. Users subscribe via the Apple App Store or Google Play Store, with optional participation in clinical research through a separate research platform.
Product overview
BrainEye offers a mobile health technology platform centered on its smartphone-based eye-tracking application for brain health assessment. The core BrainEye App connects to the BrainEye Cloud Platform, which processes eye movement data and applies machine learning algorithms to detect brain health changes. An optional Research Platform module enables clinical research participation. The platform's primary test modality is the Smooth Pursuit (SMP) test, which captures ocular motor biomarkers to assess brain function. The company also operates a concussion research program conducted in partnership with Monash University.
Differentiator
Problem solved
Functional benefit
Products and services
- BrainEye App
Quantifiable outcome
- Traditional neurological examination evaluates approximately 10% of the brain, while BrainEye's assessment of the visual-ocular motor system evaluates over 50% of the brain
- +1 more outcomes
Companies that use BrainEye
Customer profileSegments5 records
Ideal customer profiles4 records
BrainEye technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
BrainEye partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Monash University Neuroscience DepartmentcoreMonash University Neuroscience Department conducts independent research overseeing BioEye concussion trials. The partnership involves clinical validation of the BrainEye technology platform through rigorous scientific research.
- AWS (Amazon Web Services)coreBrainEye processes and stores all data, including Personal Information, on secure AWS cloud servers. AWS provides the cloud infrastructure for the company's data processing, storage, and analysis operations.
- Bellberry Human Research Ethics CommitteecoreThe Bellberry Human Research Ethics Committee in Australia has reviewed and approved BrainEye's clinical research studies in accordance with the Australian National Statement on Ethical Conduct in Human Research.
- Emmanuel PetitminorIconic French footballer and World Cup champion Emmanuel Petit serves as BrainEye Brand Ambassador, bringing global recognition and commitment to excellence to the mission of revolutionizing brain health. His advocacy helps connect with a wider audience, spreading awareness about managing brain health.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
BrainEye competitors and assessment
Company assessmentDirect peers
- Oculogica: Eye-tracking concussion and neurological diagnostic platform (e.g., Eye-Sync/BOXS) commercialized to clinics and sports organizations — comparable eye-tracking modality and concussion GTM.
- RightEye: Eye-tracking based health-assessment company whose core technology analyses ocular motility for brain/performance diagnostics — directly comparable to BrainEye's smooth-pursuit, ocular-motor biomarker approach.
- Cumulus Neuroscience: Smartphone-based cognitive and neurological assessment platform using AI/ML on consumer devices to detect and monitor conditions such as depression, MS, and Alzheimer's — the closest direct competitor to BrainEye in modality and target.
- SyncThink: Eye-tracking derived balance/concussion assessment tool used by sports teams and clinicians; the closest direct competitor in the sports/concussion sub-segment BrainEye explicitly targets.
- Linus Health: Digital brain-health platform combining smartphone/tablet-based cognitive and speech assessment with AI for early detection of neurological impairment; overlaps BrainEye on smartphone-delivered, AI-analyzed brain biomarkers.
Broad incumbents
- Akili Interactive: Public digital-therapeutics company with FDA-cleared, consumer-delivered cognitive assessment/intervention products; competes for the same at-home, smartphone-delivered brain-health user.
- Cogstate: Established cognitive testing company serving clinical trials and healthcare providers; an incumbent in computerized brain-health assessment overlapping BrainEye's neurological-monitoring value proposition.
- Cambridge Cognition: Provider of digital cognitive assessments used in clinical trials and research; comparable in the digital brain-health assessment and trials-services category.
- Apple (Health / Vision Pro): Platform incumbent that ships eye-tracking, on-device ML, and a Health ecosystem across iPhone and Vision Pro — a primary platform risk for any smartphone/eye-tracking health play.
Emerging players
- Posit Science (BrainHQ): Brain-training and cognitive-assessment platform targeting healthy-aging and clinical populations; overlaps BrainEye on longitudinal brain-health tracking and consumer health positioning.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BrainEye social profiles
Digital presenceBrainEye financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrainEye leadership team
Management profileNumber of profiles
Profiles6 records
BrainEye funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrainEye M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrainEye
What does BrainEye do?
BrainEye offers a smartphone-based eye-tracking application that measures brain health by tracking eye responses to visual stimuli in 60 seconds. The app captures ocular motor biomarkers via the smartphone camera, uploads them to a cloud platform, and applies AI/ML analysis to deliver real-time results that can indicate concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. Users subscribe via the Apple App Store or Google Play Store, with optional participation in clinical research through a separate research platform.
Is BrainEye a public or private company?
BrainEye is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BrainEye founded?
BrainEye was founded in 2020. It employs 51 to 100 people.
Where is BrainEye based?
BrainEye is headquartered in Sydney, Australia, in the Oceania region.
How does BrainEye make money?
Two revenue lines are on record. App Subscription is the primary driver. The others are in-App Purchases.
Who are BrainEye's main competitors?
Direct peers on record are Oculogica, RightEye, Cumulus Neuroscience, SyncThink and Linus Health. Broad incumbents are Akili Interactive, Cogstate, Cambridge Cognition and Apple (Health / Vision Pro). Posit Science (BrainHQ) is listed as an emerging player.
Does BrainEye have an API?
No public API is recorded for BrainEye.
What industry is BrainEye in?
BrainEye's product category is Digital Health Brain Assessment Software. Its primary akta.pro industry code is HLALAGAC, Neurology Telemedicine Platforms, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 621320 and its SIC code is 3827.